GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Clinical trials for GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested to fight stomach cancer before surgery
Disease control OngoingThis trial is testing whether adding two newer drugs (apatinib and camrelizumab) to standard chemotherapy helps people with advanced stomach cancer. The treatment is given both before and after surgery. The goal is to see if this combination can better shrink the tumor before sur…
Matched conditions: GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug combo trial aims to shrink tumors before stomach cancer surgery
Disease control OngoingThis study is testing whether giving patients with advanced stomach or gastroesophageal cancer a combination of immunotherapy and chemotherapy drugs before surgery can help shrink their tumors. The goal is to see if this 'pre-surgery' treatment makes the subsequent operation more…
Matched conditions: GASTRIC AND GASTROESOPHAGEAL JUNCTION (GEJ) ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC